MRMNasdaqServices-Personal ServicesFiscal year ends December 31

Medirom Healthcare Technologies Inc.

Financials through fiscal 2024, year ended Dec 31, 2024

$0.36+0.00 (+0.14%)

Close on Oct 19, 2026

Medirom Healthcare Technologies Inc. income statement

AnnualQuarterlyTTM

JPY USD

Millions of JPY, except per-share data. Shares in millions.

Line item	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31
Revenue	8,299	6,828	6,954	5,410	3,342	3,908
Cost of Revenue	6,053	5,259	5,052	–	–	–
Gross Profit	2,246	1,569	1,902	–	–	–
Selling, General & Admin	2,242	1,960	1,805	1,823	1,069	872
Advertising Expenses	155	162	135	131	92	78
Total Costs & Expenses	8,317	7,220	6,857	5,880	4,088	3,874
Operating Income	-18	-392	97	-471	-746	34
Interest Expense	50	37	9.80	12	13	14
Interest & Investment Income	0.01	1.11	6.07	0.84	1.33	1.34
Income from Equity Investments	–	–	–	–	–	0.56
Other Non-Operating Income	66	412	83	56	119	-1.61
Asset Impairment Charges	0	0	0	0	0	0
Gain (Loss) on Sale of Assets	41	414	–	-2.69	–	-9.60
Pretax Income	48	21	180	-414	-627	33
Income Tax Expense	-90	-94	31	576	-88	16
Net Income incl. Noncontrolling Interests	138	115	149	-991	-539	17
Minority Interest in Earnings	–	-0.36	–	–	–	–
Net Income	149	115	149	-991	-539	17
Net Income to Common	–	–	149	-991	-539	17
EPS (Basic)(per share)	29.13	23.64	30.54	-203.13	-133.97	4.63
EPS (Diluted)(per share)	28.52	22.34	27.23	-203.13	-133.97	4.06
Shares Outstanding (Basic, Weighted)(shares)	5.11	4.88	4.88	4.88	4.02	3.75
Shares Outstanding (Diluted, Weighted)(shares)	5.85	5.17	5.47	4.88	4.02	4.27
EBITDA	272	-139	281	-344	-684	81

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2025

Profitability, FY2024

Gross margin: 27.1%
Operating margin: -0.2%
Net margin: 1.8%
Return on equity, FY2024: 26.0%

Financial strength

Current ratio: 0.24
Debt to equity: 8.11
Debt to assets: 24.6%
Cash to current liabilities: 0.7%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.